United Arab Emirates Approves AstraZeneca Baxfendy for Uncontrolled Hypertension Treatment
The UAE has approved AstraZeneca’s new hypertension treatment, Baxfendy, becoming the first country to clear the medicine for patients with difficult blood pressure conditions. The approval supports faster access to advanced healthcare and gives hope to people whose blood pressure stays high despite regular medication.
Why The Approval Matters
Health officials said the treatment targets aldosterone, a hormone linked to rising blood pressure. By reducing this hormone, the medicine may help patients manage resistant hypertension more effectively. In addition, the treatment comes in 1 mg and 2 mg doses for adults who need extra support alongside standard therapies.
The Emirates Drug Establishment approved the drug after reviewing results from two Phase III clinical trials, called BaxHTN and Bax24. Researchers reported meaningful reductions in uncontrolled blood pressure during both studies. Therefore, officials viewed the findings as strong evidence supporting the treatment’s safety and effectiveness.
Growing Focus On Heart Health
Hypertension remains one of the most common chronic conditions in the UAE. Experts estimate that nearly one in three adults lives with high blood pressure. However, many patients still struggle to control the condition even after taking several medicines regularly.
What Officials And Experts Said
Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, said the approval reflects the UAE’s commitment to modern healthcare solutions. Meanwhile, AstraZeneca Gulf President Sameh El Fangary described the decision as an important step for cardiovascular treatment innovation.
As a result, doctors and patients may soon gain access to another option for managing difficult hypertension cases and improving long-term heart health.
Medical experts also encourage exercise, balanced diets, and health screenings to reduce cardiovascular risks. Furthermore, early diagnosis can prevent complications, including strokes, kidney disease, and heart failure. Officials believe wider awareness about resistant hypertension will help residents seek timely treatment and improve wellbeing.
